Patients with CNS-related symptoms in the baseline, n = 28 | Before the initiation of alectinib | After the treatment of alectinib |
---|---|---|
Number of patients who needed mannitol or corticosteroids | 18 (64.3%) | 3 (10.7%) |
Number of patients who didn't need mannitol or corticosteroids | 10 (35.7%) | 25(89.3%) |